Andrew D. Zelenetz

Sloan-Kettering Inst Can Research

$2,388,579

Attributed

$2,388,579

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $3M · FY2016–20

$5M$3.8M$2.5M$1.3M$0

'16

'17

'18

'19

'20

Funding mix

By agency

NIH$13,286,698 · 5

By mechanism

P50$13,286,698 · 5

Top collaborators

Anas Younes3 shared
Riccardo Dalla-Favera2 shared

Most similar at Sloan-Kettering Inst Can Research

Same institution · by research overlap

Others in their field

Top investigators on “S Lymphoma”

David Heimbrook · Leidos Biomedical Research, Inc.$171,980,034
Richard L Schilsky · University Of Chicago$120,036,663
Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$113,682,224
Ronald T Mitsuyasu · University Of California Los Angeles$103,553,444
Monica M Bertagnolli · Strang Cancer Prevention Center$61,393,123
Charles A Coltman · Southwest Oncology Group$55,198,633

Research focus

S LymphomaLymphomaClinical TrialsBasePre-Clinical ModelIn VivoProteinsOncogenicPathologicGeneticInhibitor/AntagonistMutationBcl2 GeneLarge Cell Diffuse Non-Hodgkin&AposClinical EfficacyHistone Deacetylase InhibitorPhase Ii Clinical TrialsMolecularEp300 GeneBiological MarkersEventB-LymphocytesCellsRelapse